Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Database | Last Updated |
---|---|
ChEBI | February 3, 2022 |
KEGG | February 3, 2022 |
LIPID MAPS Structure Database | February 3, 2022 |
LipidBank | February 3, 2022 |
PubChem | February 3, 2022 |
Main Class | Sub Class | LM ID | Common Name ▼ | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc6Cer(d18:1/22:0)
|
1675.976042
|
C80H145N3O33
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc6Cer(d18:1/20:0)
|
1647.944742
|
C78H141N3O33
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc6Cer(d18:1/18:0)
|
1619.913442
|
C76H137N3O33
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc6Cer(d18:1/16:0)
|
1591.882142
|
C74H133N3O33
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc5Cer(d18:1/26:1(17Z))
|
1567.970167
|
C78H141N3O28
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc5Cer(d18:1/26:0)
|
1569.985817
|
C78H143N3O28
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc5Cer(d18:1/24:1(15Z))
|
1539.938867
|
C76H137N3O28
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc5Cer(d18:1/24:0)
|
1541.954517
|
C76H139N3O28
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc5Cer(d18:1/22:0)
|
1513.923217
|
C74H135N3O28
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
nLc5Cer(d18:1/20:0)
|
1485.891917
|
C72H131N3O28
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01